U2Bio Co., Ltd. (KOSDAQ:221800)
20,750
-1,850 (-8.19%)
At close: Mar 19, 2026
U2Bio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2014 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '14 Dec 31, 2014 |
Cash & Equivalents | 1,342 | 16,489 | 35,290 | 1,433 | 906.21 |
Short-Term Investments | 26,900 | 16,500 | - | 34,000 | 100 |
Trading Asset Securities | 3,524 | 1,001 | 1,501 | 1,489 | - |
Cash & Short-Term Investments | 31,767 | 33,991 | 36,792 | 36,921 | 1,006 |
Cash Growth | -6.54% | -7.61% | -0.35% | 3569.37% | 351.03% |
Accounts Receivable | 7,901 | 6,944 | 7,300 | 9,935 | 9,328 |
Other Receivables | 404.94 | 532.39 | 90.76 | 247.23 | 23.04 |
Receivables | 8,352 | 7,477 | 7,391 | 10,183 | 9,436 |
Inventory | 737.99 | 727.58 | 782.8 | 695.58 | 393.94 |
Prepaid Expenses | 2.68 | 2.76 | 205.52 | 2.52 | - |
Other Current Assets | 177.57 | 134.37 | 0.62 | 71.15 | 0.78 |
Total Current Assets | 41,037 | 42,332 | 45,172 | 47,873 | 10,837 |
Property, Plant & Equipment | 960.63 | 1,186 | 1,549 | 1,871 | 585.01 |
Long-Term Investments | 8,927 | -0 | 0 | -0 | 109.85 |
Other Intangible Assets | 439.67 | 363.74 | 364.62 | 172.87 | - |
Long-Term Deferred Tax Assets | - | - | 1,281 | 615.14 | - |
Long-Term Deferred Charges | 581.22 | 656.76 | 365.31 | - | 213.93 |
Other Long-Term Assets | 504.39 | 444.73 | 466.95 | 496.41 | 148.22 |
Total Assets | 52,511 | 44,983 | 49,199 | 51,028 | 11,959 |
Accounts Payable | 2,681 | 2,730 | 3,711 | 4,656 | 1,610 |
Accrued Expenses | 1,064 | 994.14 | 961.87 | 3,445 | 75.43 |
Short-Term Debt | - | - | - | - | 804 |
Current Portion of Long-Term Debt | - | - | - | - | 1,793 |
Current Portion of Leases | 288.48 | 285.83 | 260.31 | 416.95 | - |
Current Income Taxes Payable | - | - | - | 2,662 | - |
Other Current Liabilities | 2,389 | 2,603 | 3,070 | 3,454 | 1,494 |
Total Current Liabilities | 6,422 | 6,614 | 8,003 | 14,634 | 5,776 |
Long-Term Debt | - | - | - | - | 1,782 |
Long-Term Leases | 154.14 | 172.23 | 191.96 | 104.64 | - |
Pension & Post-Retirement Benefits | 3,580 | 3,725 | 2,983 | 2,392 | 326.26 |
Other Long-Term Liabilities | 51.91 | 44.11 | 30.05 | 52.88 | 195.97 |
Total Liabilities | 10,209 | 10,555 | 11,208 | 17,184 | 8,080 |
Common Stock | 6,772 | 5,644 | 5,644 | 1,263 | 723.33 |
Additional Paid-In Capital | 21,697 | 13,935 | 13,935 | 13,426 | 2,884 |
Retained Earnings | 13,826 | 14,858 | 18,422 | 19,164 | 271.68 |
Comprehensive Income & Other | 6.91 | -8.66 | -8.66 | -8.66 | - |
Shareholders' Equity | 42,302 | 34,427 | 37,991 | 33,844 | 3,879 |
Total Liabilities & Equity | 52,511 | 44,983 | 49,199 | 51,028 | 11,959 |
Total Debt | 442.62 | 458.06 | 452.27 | 521.59 | 4,379 |
Net Cash (Debt) | 31,324 | 33,533 | 36,340 | 36,400 | -3,373 |
Net Cash Growth | -6.59% | -7.72% | -0.17% | - | - |
Net Cash Per Share | 2689.75 | 2974.91 | 3522.53 | 3604.03 | -2333.98 |
Filing Date Shares Outstanding | 12.72 | 11.29 | 11.29 | 10.1 | 1.45 |
Total Common Shares Outstanding | 12.72 | 11.29 | 11.29 | 10.1 | 1.45 |
Working Capital | 34,615 | 35,718 | 37,169 | 33,239 | 5,061 |
Book Value Per Share | 3325.28 | 3050.13 | 3365.89 | 3350.98 | 2684.51 |
Tangible Book Value | 41,863 | 34,064 | 37,627 | 33,671 | 3,879 |
Tangible Book Value Per Share | 3290.72 | 3017.91 | 3333.58 | 3333.87 | 2684.51 |
Machinery | 2,482 | 2,382 | 2,331 | 3,821 | 1,438 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.